Fat-soluble statins linked to lower odds of Parkinson's

07/25/2013 | HealthDay News

Patients who stopped taking fat-soluble statins had a 58% greater risk of developing Parkinson's disease than those who continued taking the cholesterol-lowering drugs, according to a study of almost 44,000 people. The rate of Parkinson's disease was about double among patients who took water-soluble statins compared with those treated with fat-soluble statins. The findings appear in the journal Neurology.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Fort Worth, TX